Watch, listen, and make treatment decisions as Charles B. Hicks, MD, leads you through this interactive presentation exploring the application of various tools and approaches, including resistance and tropism tests, to assess the activity of antiretroviral agents to individualize treatment for antiretroviral-experienced patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the role of resistance testing in assessing the potential activity of an antiretroviral regimen
- Summarize clinical data pertaining to the impact of NRTI and NNRTI resistance on the efficacy of subsequent lines of therapy with agents from these classes
- Define what is meant by a high genetic barrier to resistance and cite clinical examples as they relate to PI treatment
- Discuss the role of agents from new classes in contributing to the number of active agents in an antiretroviral regimen
- Summarize clinical evidence regarding the ideal number of active agents that should be included in a new antiretroviral regimen for treatment-experienced patients